Sidney & Lois Eskenazi Hospital
Indianapolis, Indiana, 46202, United States
Location status: Recruiting
Location contact
Lauren Stewart, MD
CONTACT
Lauren Stewart, MD
PRINCIPAL_INVESTIGATOR
Shuhei Misawa, BS
CONTACT
NCT Number: NCT07119658
The objective of this study is to pilot a multifaceted, optimized intervention for metabolic syndrome (MetS) in emergency department patients to establish feasibility. Participants (n=20) will be randomized to intervention or control (usual care). The composite intervention will include an educational video outlining the adverse effects of MetS and the benefit of walking, a written exercise prescription with a defined goal of walking 150 minutes per week, a Fitbit accelerometer device, resources for healthy eating practices, periodic text message reminders, and an urgent referral to primary care and our health system's Healthy Me clinic for follow-up visit. Investigators hypothesize that this approach will change patient understanding and motivation to increase physical activity and healthy eating habits.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Indianapolis, Indiana, 46202, United States
Location status: Recruiting
Lauren Stewart, MD
CONTACT
Lauren Stewart, MD
PRINCIPAL_INVESTIGATOR
Shuhei Misawa, BS
CONTACT
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The composite intervention includes six components: 1. All patients will be provided a Fitbit Charge device at ED discharge with instructions to wear on their wrist for study duration. 2. Participants in the intervention group will first watch a brief (~5 minute) educational video outlining the adverse effects of MetS and the benefit of walking, via iPad tablet. 3. Participants in the intervention group will also be given accompanying written "exercise prescription" encouraging them to walk 150 minutes per week. 4. Reminder texts encouraging continued walking behavior (i.e. "Remember to get in your steps!") will be sent to the intervention group, at approximate 2-3x/week intervals for the 3-month follow-up period. 5. The intervention group will also be provided written resources for healthy eating practices upon ED discharge. 6. All intervention group participants will receive referrals into primary care clinic and the Eskenazi Health "Healthy Me" Program for follow-up.
Time frame: From enrollment to the end of the 3 month study period
Investigators will collect activity data utilizing a Fitbit accelerometer device. The primary outcome will be the mean number of daily steps averaged from 3 months of monitoring, compared between groups.
Time frame: From enrollment to the end of the 3 month study period
Investigators will collect activity data utilizing a Fitbit accelerometer device. As a secondary outcome, investigators will measure and compare minutes of moderate to vigorous physical activity (MVPA), as this metric will incorporate intensity of activity.
Time frame: At enrollment and 3 month follow-up
Participants will complete the Dietary Screener Questionnaire survey at baseline and 3-months.
Time frame: At enrollment and 3 month follow-up
Participants will complete the International Physical Activity Questionnaire survey at baseline and 3-months. This is reported on a continuous scale as physical activity metabolic equivalent of task (MET)-min per day or week.
Time frame: At enrollment and 3 month follow-up
Participants will complete the NIH PROMIS General Life Satisfaction -- Short Form 5a survey at baseline and 3-months. (min value: 5, max value: 35, higher score = higher life satisfaction)
Time frame: At enrollment and 3 month follow-up
Participants will complete the NIH PROMIS Physical Function -- Short Form 4a survey at baseline and 3-months. (min value: 4, max value: 20, higher score = higher physical functioning)
Time frame: At enrollment and 3 month follow-up
Participants will complete the NIH PROMIS Self-Efficacy for Managing Chronic Conditions - Managing Daily Activities -- Short Form 8a survey at baseline and 3-months. (min value: 8, max value: 40, higher score = higher self-efficacy)
Time frame: From enrollment to 3 month follow-up
Investigators will assess ED recidivism over the 3-month follow-up period, which will be defined as any repeat visit to the emergency department over the study period. This will be assessed primarily through review of the electronic medical record for any new ED encounter that occurred after initial enrollment date.
Time frame: From enrollment to 3 month follow-up
Investigators will determine whether intervention patients were able to successfully follow up in the health system's outpatient clinic with the referral provided. This will be determined through review of the electronic medical record.
Time frame: From enrollment to 3 month follow-up
Investigators will describe the number of totals days participants actually wore the Fitbit accelerometer device over the study period, allowing for activity data collection.
Time frame: This will be collected on Day 1 (i.e. day of screening and approaching for enrollment)
As an additional exploration, we will collect pertinent data on the screening and enrollment process, including demographic data on which patients are screened, approached, and ultimately enrolled. We will ask those who decline enrollment to briefly provide us information (i.e. short-form, open-ended response) on why they are declining to participate, to gain further knowledge on the targeted ED population for this intervention.
Time frame: At 3-month follow-up (for those in intervention group)
To better understand reasons for failure and success of adherence to the composite intervention, we will also conduct semi-structured interviews at three-month follow-up of patients in the intervention group. Thematic analysis will be performed to identify theoretical constructs, processes, and themes surrounding the patients' experience with the composite intervention.
Indiana University
Other
Acronym: METS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06694012
Arterial Occlusive Diseases, Arteriosclerosis
Sakai, Osaka, Japan
View Trial DetailsNCT07043166
Body Weight, Bone Diseases
Shanghai, Shanghai Municipality, China
View Trial DetailsNCT02037321
Arthritis, Body Weight
Toronto, Ontario, Canada
View Trial DetailsNCT01630980
Body Weight, Cardiovascular Diseases
Toronto, Ontario, Canada
View Trial Details